| Dr Thomas H Metcalf, MD | |
|
988 Oak Ridge Tpke, Suite 140, Oak Ridge, TN 37830-6930 | |
| (865) 483-7415 | |
| (865) 483-7980 |
| Full Name | Dr Thomas H Metcalf |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 988 Oak Ridge Tpke, Oak Ridge, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669561023 | NPI | - | NPPES |
| 3379961 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD 11305 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas H Metcalf, MD 988 Oak Ridge Tpke, Suite 140, Oak Ridge, TN 37830-6930 Ph: (865) 483-7415 | Dr Thomas H Metcalf, MD 988 Oak Ridge Tpke, Suite 140, Oak Ridge, TN 37830-6930 Ph: (865) 483-7415 |
News Archive
Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has formed a consortium to develop thermostable technology to advance RiVax(TM) and other rapidly acting vaccines. Soligenix received a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to support this work.
Osteoarthritis is a degenerative joint disease and the most common cause of disability today. It was once considered a problem of the old but it is now commonly diagnosed in those as young as the mid-twenties and early thirties. According to the Arthritis Foundation, about four million, quality-adjusted life years are lost due to knee osteoarthritis alone.
Concerns about terrorist attacks, the prospect of a rogue nation using nuclear weapons and the Fukushima power plant accident in Japan are fostering efforts to develop a new family of drugs that everyone hopes will never be used, according to an article in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
› Verified 7 days ago
Dr. Scott W Peters, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 988 Oak Ridge Tpke, Suite 140, Oak Ridge, TN 37830 Phone: 865-483-7415 | |
Dr. Kathryn J Hayes, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 988 Oak Ridge Tpke, Suite 140, Oak Ridge, TN 37830 Phone: 865-483-7415 Fax: 865-483-7980 | |
Dr. Joseph B Carter, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 988 Oak Ridge Tpke, Suite 140, Oak Ridge, TN 37830 Phone: 865-483-7415 Fax: 865-483-7980 | |
Dr. Charles E Darling, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 200 New York Ave Ste 150, Oak Ridge, TN 37830 Phone: 865-481-0200 Fax: 865-481-3085 | |
Regina Dill, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 988 Oak Ridge Tpke Ste 140, Oak Ridge, TN 37830 Phone: 865-483-7415 Fax: 865-483-7980 | |
Dr. Lalita Krishnan, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 988 Oak Ridge Tpke Ste 140, Oak Ridge, TN 37830 Phone: 865-483-7415 Fax: 865-483-7980 |